ALZ — Alzinova AB Share News
0.000.00%
- SEK148.49m
- SEK135.99m
Brief: Alzinova Rights Issue Subscribed To 85%
Brief: Alzinova Gets Letters Of Intent Ongoing Rights Issue
Brief: Alzinova Resolves On Rights Issue Of Shares Of About SEK 35.7 Mln
Brief: Final Data Confirm Positive Phase 1b Results With Alzinova's ALZ-101 Against Alzheimer's Disease
Brief: Alzinova Q4 Loss Before Tax Widens To SEK 6.6 Mln
Brief: Alzinova Appoints Erik Kullgren As Permanent CFO
Brief: Alzinova Reports Positive Results From Phase 1B Extension Part Of Alz-101 Study
Brief: Alzinova Q3 Loss After Financial Items Widens To TSEK 4,151
Brief: Alzinova Appoints Tord Labuda As CEO
Brief: Maida Vale Capital Increases Holding In Alzinova
Brief: Alzinova Appoints Carol Routledge As Acting CEO
Brief: Alzinova’S Rights Issue Oversubscribed
Brief: New Positive Safety Review For Alzinova's Phase 1B Study
Brief: Alzinova Q1 Adj. EPS at SEK -0.11
Brief: Alzinova Q1 Net Sales Amounted To SEK 30,000
Brief: Alzinova Resolves On Rights Issue Of About SEK 34.4 Mln
Brief: Kristina Torfgard To Leave CEO Position At Alzinova
Brief: Alzinova Appoints Erik Kullgren As Interim CFO
Brief: Alzinova Proposes That No Dividends Are Paid For 2023